GenMark Diagnostics Company Profile (NASDAQ:GNMK)

Analyst Ratings

Consensus Ratings for GenMark Diagnostics (NASDAQ:GNMK) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $8.96 (12.69% downside)

Analysts' Ratings History for GenMark Diagnostics (NASDAQ:GNMK)
Show:
DateFirmActionRatingPrice TargetActions
6/17/2016Needham & Company LLCInitiated CoverageBuy$11.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Raymond James Financial Inc.Lower Price TargetOutperform$9.00 -> $7.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Cowen and CompanyLower Price Target$7.25 -> $6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016JPMorgan Chase & Co.Lower Price TargetOverweight$15.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016BTIG ResearchReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for GenMark Diagnostics (NASDAQ:GNMK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
7/28/2016Q216($0.33)($0.30)$9.62 million$12.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2016Q116($0.29)($0.30)$10.67 million$11.06 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415($0.27)($0.21)$12.34 million$13.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315($0.31)($0.27)$8.24 million$8.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.31)($0.29)$7.59 million$7.65 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.24)($0.24)$10.10 million$10.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.28)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.32)($0.23)$5.80 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($0.29)($0.27)$4.79 million$6.55 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114($0.25)($0.21)$6.40 million$7.91 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2014Q413($0.22)($0.21)$6.06 million$6.45 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q313($0.27)($0.24)$4.60 million$4.64 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.26)($0.25)$5.05 million$5.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q1 2013($0.17)($0.13)$9.53 million$11.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2011($0.32)($0.31)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2011($0.45)($0.39)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011($0.49)($0.56)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2011($0.52)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GenMark Diagnostics (NASDAQ:GNMK)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for GenMark Diagnostics (NASDAQ:GNMK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GenMark Diagnostics (NASDAQ:GNMK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/7/2016Hany MassaranyCEOSell1,188$8.98$10,668.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Michael GleesonSVPSell868$8.80$7,638.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Ingo ChakravartySVPSell184$8.53$1,569.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Ingo ChakravartySVPSell582$5.42$3,154.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Eric StierSVPSell363$5.79$2,101.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Hany MassaranyCEOSell1,160$5.79$6,716.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Michael KagnoffDirectorBuy2,500$4.90$12,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Hany MassaranyCEOSell1,193$5.76$6,871.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Michael GleesonSVPSell559$5.76$3,219.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2016Eric StierSVPSell365$4.87$1,777.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Ingo ChakravartySVPSell697$5.04$3,512.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Hany MassaranyCEOSell9,173$4.99$45,773.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Michael GleesonSVPSell3,083$4.99$15,384.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2016Hany MassaranyCEOSell648$6.80$4,406.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2016Michael GleesonSVPSell227$6.80$1,543.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Eric StierSVPSell240$7.26$1,742.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Hany MassaranyCEOSell1,735$7.26$12,596.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Hany MassaranyCEOSell3,571$7.71$27,532.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Michael GleesonSVPSell1,664$7.62$12,679.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Lisa M GilesDirectorBuy4,000$6.60$26,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Michael KagnoffDirectorBuy5,000$6.70$33,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Scott MendelCFOBuy10,000$6.47$64,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Daryl FaulknerDirectorBuy4,000$7.33$29,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Jennifer Anne WilliamsSVPSell14,245$9.98$142,165.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Jennifer Anne WilliamsSVPSell9,245$10.00$92,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015Hany MassaranyCEOSell1,683$9.64$16,224.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015Jennifer Anne WilliamsSVPSell18,280$9.99$182,617.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2015Jennifer Anne WilliamsSVPSell1,867$9.59$17,904.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015Hany MassaranyCEOSell3,865$9.62$37,181.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Scott MendelCFOBuy10,000$9.10$91,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Hany MassaranyCEOSell1,698$9.12$15,485.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Michael GleesonSVPSell1,595$9.55$15,232.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Hany MassaranyCEOSell3,486$9.47$33,012.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Hany MassaranyCEOSell5,942$11.52$68,451.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Jennifer Anne WilliamsSVPSell30,000$12.56$376,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2015Hany MassaranyCEOSell28,110$11.88$333,946.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2015Jeffrey Alan HawkinsSVPSell6,832$12.01$82,052.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Jennifer Anne WilliamsSVPSell722$11.83$8,541.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Michael KagnoffDirectorBuy5,000$11.84$59,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Ingo ChakravartySVPSell3,310$12.06$39,918.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2015Hany MassaranyCEOSell5,982$12.88$77,048.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015Hany MassaranyCEOSell4,858$13.00$63,154.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Kevin C OboyleDirectorSell291$12.40$3,608.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Eric StierSVPSell235$12.51$2,939.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Hany MassaranyCEOSell1,700$12.51$21,267.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Hany MassaranyCEOSell3,300$12.06$39,798.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Jeffrey Alan HawkinsSVPSell1,350$12.06$16,281.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Jon Faiz KayyemSVPSell6,000$11.01$66,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2014Hany MassaranyCEOSell5,804$9.00$52,236.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2014Michael GleesonSVPSell55$9.10$500.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Hany MassaranyCEOSell1,678$9.86$16,545.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Hany MassaranyCEOSell3,795$10.04$38,101.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Michael GleesonSVPSell1,833$10.04$18,403.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Michael GleesonSVPSell52$11.15$579.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Jon Faiz KayyemSVPSell6,000$13.60$81,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014Hany MassaranyCEOSell1,115$11.64$12,978.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Jon Faiz KayyemSVPSell1,483$10.69$15,853.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014Hany MassaranyCEOSell2,700$10.67$28,809.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Kevin C OboyleDirectorSell1,603$10.98$17,600.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2014Jon Faiz KayyemSVPSell6,000$11.06$66,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Richard SlanskyCFOSell2,302$9.26$21,316.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2014Hany MassaranyCEOSell3,985$9.87$39,331.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2014Jennifer Anne WilliamsSVPSell30,195$9.97$301,044.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014Jon Faiz KayyemSVPSell7,355$12.46$91,643.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Jon Faiz KayyemSVPSell50,000$14.05$702,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Hany MassaranyCEOSell4,698$13.31$62,530.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013Michael GleesonSVPSell2,211$11.14$24,630.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2013Hany MassaranyCEOSell3,968$11.14$44,203.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2013Hany MassaranyCEOSell3,925$12.05$47,296.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Jon Faiz KayyemSVPSell6,000$12.14$72,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Jeffrey Alan HawkinsSVPSell1,890$11.60$21,924.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Hany MassaranyCEOSell2,354$11.60$27,306.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Jon Faiz KayyemSVPSell1,545$11.60$17,922.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013Jon Faiz KayyemSVPSell1,310$10.15$13,296.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Jon Faiz KayyemSVPSell6,000$10.40$62,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for GenMark Diagnostics (NASDAQ:GNMK)
DateHeadline
07/28/16 08:46 PMGenMark Diagnostics : to Present at the 36th Annual Canaccord Genuity Growth Conference
07/28/16 08:46 PMGenMark Diagnostics Reports Q2 Financial Results
07/28/16 05:18 PMGenMark Diagnostics reports 2Q loss -
07/28/16 06:07 AMQ2 2016 GenMark Diagnostics Inc Earnings Release - After Market Close -
07/27/16 04:48 PMGenMark Diagnostics to Present at the 36th Annual Canaccord Genuity Growth Conference - [at noodls] - July 27, 2016 CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, ...
07/25/16 04:20 PMExpected For GenMark Diagnostics, Inc. (NASDAQ:GNMK) Sales Of $66.845 - Investor Newswire
07/24/16 08:42 AMIs $15 Price Target Attainable For GenMark Diagnostics, Inc. (NASDAQ:GNMK)? - Investor Newswire
07/21/16 01:04 PMETF’s with exposure to GenMark Diagnostics, Inc. : July 21, 2016 -
07/21/16 07:50 AMGenmark Diagnostics Incorporated (NASDAQ:GNMK) Shorted Shares Increased By 0.98% - Consumer Eagle
07/19/16 10:24 AMWere Analysts Bearish GenMark Diagnostics, Inc (NASDAQ:GNMK) This Week? - Consumer Eagle
07/18/16 04:29 PMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Expected To Post Sales Of $66.845 - Investor Newswire
07/18/16 04:29 PMShare Performance Summary for: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph
07/17/16 03:53 PMShares Moving Down on the Week: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Engelwood Daily
07/16/16 04:04 PMShares Experiencing a Downtrend: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - TGP
07/15/16 03:17 PMCrowd Rating and Earnings Recap for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Telanagana Press
07/14/16 04:25 PMGenmark Diagnostics Incorporated (NASDAQ:GNMK) Sellers Increased By 0.65% Their Shorts - Consumer Eagle
07/14/16 04:12 PMGenMark Diagnostics Schedules Second Quarter 2016 Financial Results Conference Call for July 28, 2016 - [Business Wire] - GenMark Diagnostics, Inc. today announced that it plans to release its second quarter earnings results after market close on Thursday, July 28, 2016. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m.
07/14/16 07:43 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 08:40 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 08:40 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Yearly Sales Target At $66.845 - Investor Newswire
07/12/16 08:40 AMTrading Performance and Target Watch for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph
07/12/16 08:40 AMNew Broker Ratings For GenMark Diagnostics, Inc. (GNMK) - FTSE News
07/10/16 08:42 AMWall Street Ratings and Target Price Views on GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Telanagana Press
07/08/16 04:14 PMIs $15 Within Reach For GenMark Diagnostics, Inc. (NASDAQ:GNMK)? - Investor Newswire
07/07/16 04:19 PMHeightened Volatility Check on: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Engelwood Daily
07/07/16 04:19 PMBroker Outlook For GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard
07/07/16 07:06 AMTime to Buy GenMark Diagnostics, Inc After Today's Huge Increase? - Press Telegraph
07/07/16 07:06 AMStock Rating Watch and Earnings Insight for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph
07/05/16 04:08 PMWere Analysts Bearish GenMark Diagnostics, Inc (NASDAQ:GNMK) This Week? - Press Telegraph
07/02/16 07:11 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Expected to Reach Highs Of $15 - Investor Newswire
07/01/16 07:02 AMGenmark Diagnostics Incorporated (NASDAQ:GNMK) Shorted Shares Increased 0.65% After Market Selling - Press Telegraph
07/01/16 07:02 AMGenMark Diagnostics, Inc. (GNMK) Current Analyst Ratings - Fiscal Standard
06/30/16 07:05 AMShare Update and Earnings Review for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph
06/30/16 07:05 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Company Rating and Target Watch - Telanagana Press
06/28/16 09:04 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 04:08 PMBroker Outlook For The Week Ahead GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard
06/27/16 08:41 AMWill GenMark Diagnostics, Inc. (NASDAQ:GNMK) Surprise This Quarter? - Investor Newswire
06/25/16 08:06 AMStrong Sell Calls Recommendations For GenMark Diagnostics, Inc. (NASDAQ:GNMK) At 0 - Investor Newswire
06/24/16 04:19 PMGenMark Diagnostics, Inc. (GNMK) Updated Price Targets - FTSE News
06/22/16 04:23 PMRecently Issued Stock Ratings For GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard
06/21/16 08:52 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Yearly Sales Projections At $66.845 - Investor Newswire
06/19/16 08:32 AMStrong Buy Calls Count For GenMark Diagnostics, Inc. (NASDAQ:GNMK) At 3 - Investor Newswire
06/17/16 04:09 AMGenMark Diagnostics Inc. (GNMK) Drops 5.31% on June 15 - Equities.com
06/15/16 04:18 PMBrokers Issue Average Price Target Of 12.07 On GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard
06/14/16 04:19 PMGENMARK DIAGNOSTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financ -
06/09/16 04:24 PMGenMark Diagnostics, Inc. (NasdaqGM:GNMK) Fundamental Star Rating Report - CML News
06/08/16 03:38 PMGenMark Achieves CE Mark for its ePlex® Sample-to-Answer System - [at noodls] - e87991c1-5e4b-4dea-9180-152f3152928b.pdf June 8, 2016 European Customer Agreements in Place for Initial Systems CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider ...
06/08/16 03:06 PMGENMARK DIAGNOSTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Fi -
06/06/16 04:07 PMGENMARK DIAGNOSTICS INC. (NASDAQ:GNMK) Financial Condition Compared to S&P 500 - CML News
06/06/16 03:38 PMGenMark Diagnostics to Present at the William Blair 36th Annual Growth Stock Conference - [at noodls] - d6d04700-a86c-4b90-95db-56b795cc2be0.pdf June 6, 2016 CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing ...

Social

About GenMark Diagnostics

GenMark Diagnostics logoGenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company. The Company focuses on developing and commercializing its eSensor detection technology. Its eSensor electrochemical technology detects multiple distinct biomarkers in a single sample. It sells its XT-8 instrument and related diagnostic and research tests (XT-8 system) in the United States. It has developed and intends to commercially launch its sample-to-answer ePlex instrument and its associated diagnostic tests, which it collectively refers to as its ePlex system, in Europe and the United States. It operates in the development, manufacturing, sales and support of instruments and molecular tests based on its eSensor detection technology segment. Over four of its diagnostic tests, which run on its XT-8 instrument, have received United States Food and Drug Administration clearance, including Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, Thrombophilia Risk Test and Respiratory Viral Panel.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GNMK
  • CUSIP:
Key Metrics:
  • Previous Close: $10.26
  • 50 Day Moving Average: $9.22
  • 200 Day Moving Average: $6.67
  • P/E Ratio: N/A
  • P/E Growth: 6.52
  • Market Cap: $439.00M
  • Beta: 0.42
  • Current Year EPS Consensus Estimate: $-1.23 EPS
  • Next Year EPS Consensus Estimate: $-1.04 EPS
Additional Links:
GenMark Diagnostics (NASDAQ:GNMK) Chart for Friday, July, 29, 2016